Browse Drug Recalls
1,317 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 1,317 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 1,317 FDA drug recalls in IL.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Apr 15, 2022 | Lidocaine Hydrochloride Oral Topical Solution, USP (Viscous) 2%, 100 mL per b... | Failed viscosity specification - product was below specificcation | Class III | Akorn, Inc. |
| Apr 1, 2022 | Esomeprazole Magnesium Delayed-Release Capsules, USP 40 mg, packaged in Unit ... | Failed Impurities/Degradation Specifications: OOS result was obtained for Any Other Individual Im... | Class II | Mylan Institutional, Inc. (d.b.a. UDL Laborator... |
| Apr 1, 2022 | Esomeprazole Magnesium Delayed-Release Capsules, USP 20 mg, packaged in Unit ... | Failed Impurities/Degradation Specifications: OOS result was obtained for Any Other Individual Im... | Class II | Mylan Institutional, Inc. (d.b.a. UDL Laborator... |
| Mar 4, 2022 | Sodium Acetate Injection, USP, 400 mEq / 100 mL (4 mEq / mL), packaged in 2 t... | Presence of particulate matter: particulates composed of carbon and oxygen with varying amounts o... | Class I | Fresenius Kabi USA, LLC |
| Feb 21, 2022 | Dexamethasone Elixir, USP 0.5 mg/5 mL, Net: 8 fl oz (237 mL) bottle, Rx only,... | Failed Impurities/Degradation Specifications: higher than permissible levels of unknown impuritie... | Class II | Morton Grove Pharmaceuticals, Inc. |
| Jan 5, 2022 | Sufentanil Citrate Injection, USP 100 mcg/2 mL (50 mcg/mL) for intravenous an... | Subpotent Drug: Out of specification for assay at the 30-month stability timepoint. | Class II | Akorn, Inc. |
| Dec 3, 2021 | Oxycodone Hydrochloride Oral Solution, USP 5 mg per 5 mL (1 mg/mL), 500 mL bo... | Labeling: Missing Label | Class III | Akorn, Inc. |
| Dec 3, 2021 | Morphine Sulfate Oral Solution 100 mg per 5 mL (20 mg/mL) 30 mL bottles, Rx o... | Labeling: Missing Label | Class III | Akorn, Inc. |
| Nov 17, 2021 | Odor-Eaters Spray Powder, Tolnaftate 1% Antifungal, packaged in a) 4 oz. aero... | Chemical contamination: Presence of benzene | Class I | Blistex Inc |
| Nov 8, 2021 | Hand Sanitizer Foam (ethyl alcohol), 62% v/v, packaged in a) 1.5 Oz. cans, ND... | Defective Container: Customer complaints for leaking bottles and dispensing issues. | Class II | Medline Industries Inc |
| Nov 1, 2021 | Acetaminophen Oral Suspension, 160 mg/5 mL, packaged in 5 mL per cup (NDC Ind... | cGMP Deviations: Product manufactured with contaminated raw ingredient. | Class II | Precision Dose Inc. |
| Nov 1, 2021 | Acetaminophen Oral Suspension, 325 mg/10.15 mL, packaged in 10.15 mL per cup... | cGMP Deviations: Product manufactured with contaminated raw ingredient. | Class II | Precision Dose Inc. |
| Oct 5, 2021 | Cetirizine hydrochloride, 10 mg tablets, 90-count bottle, Distributed by: A-S... | Labeling: Not Elsewhere classified: Product was relabeled as 90 tablet count product although it ... | Class III | A-S Medication Solutions LLC. |
| Oct 4, 2021 | Betaxolol Ophthalmic Solution, USP, 0.5%, (Betaxolol HCl 5.6 mg/mL), 5 mL dro... | Microbial Contamination of Sterile Products: Confirmed sterility failure identified during stabil... | Class II | Akorn, Inc. |
| Sep 17, 2021 | Morphine Sulfate Injection, USP, 2 mg per mL, 1 mL single dose vial, Rx only,... | Defective container: Cracked vials leading to lack of sterility assurance | Class II | Fresenius Kabi USA LLC |
| Sep 8, 2021 | TheraTears Extra (sodium carboxymethylcellulose) 0.25% Lubricant Eye Drops, 3... | Lack of Assurance of Sterility | Class II | Akorn, Inc. |
| Sep 3, 2021 | Promethazine Syrup Plain, 6.25 mg/5 mL (Promethazine Hydrochloride Syrup, USP... | CGMP Deviations: Potential concern with products manufactured using liquid sugar batches contamin... | Class II | Morton Grove Pharmaceuticals, Inc. |
| Sep 3, 2021 | Valproic Acid Oral Solution USP, (250 mg/5 mL), 1 Pint (473 mL), Rx Only, M... | CGMP Deviations: Potential concern with products manufactured using liquid sugar batches contamin... | Class II | Morton Grove Pharmaceuticals, Inc. |
| Sep 3, 2021 | Glycopyrrolate Injection, USP 4mg per 20mL, 20 mL Multi-Dose Vials, Rx only, ... | Failed Impurities/Degradation Specifications | Class III | Meitheal Pharmaceuticals Inc |
| Sep 3, 2021 | AMINOSYN II 15% An Amino Acid Injection, Sulfite-Free, 2000 mL in flexible co... | Presence of Particulate Matter: Particulate matter identified as fibers, hair, and proteinaceous ... | Class I | ICU Medical Inc |
| Sep 3, 2021 | Promethazine With Codeine Oral Solution, (Promethazine Hydrochloride 6.25 mg/... | CGMP Deviations: Potential concern with products manufactured using liquid sugar batches contamin... | Class II | Morton Grove Pharmaceuticals, Inc. |
| Aug 13, 2021 | Betamethasone Dipropionate Lotion USP (Augmented), 0.05%, packaged in a) 30 m... | Failed impurities/degradation specification: Out of Specification for an unknown impurity observe... | Class II | Akorn, Inc. |
| Aug 6, 2021 | Micafungin for Injection, 50 mg/vial, Single-Dose Vial, Sterile, Rx Only, For... | Labeling; Incorrect or Missing Package Insert: The package insert provided with the product does ... | Class II | XELLIA PHARMACEUTICALS USA, LLC |
| Aug 6, 2021 | Micafungin for Injection, 100 mg/vial, Single-Dose Vial, Sterile, Rx Only, Fo... | Labeling; Incorrect or Missing Package Insert: The package insert provided with the product does ... | Class II | XELLIA PHARMACEUTICALS USA, LLC |
| Aug 2, 2021 | Artificial Tears Ointment, Lubricant Eye Ointment, Net Wt. 3.5 g (1/8 oz.) pe... | Non-Sterility - OOS sterility testing observed during 12-month controlled room temperature stabil... | Class II | Akorn, Inc. |
| Jun 25, 2021 | Xylocaine-MPF with Epinephrine 1:200,000, (Lidocaine HCl and Epinephrine Inje... | Low out of specification results for epinephrine assay. | Class II | Fresenius Kabi USA LLC |
| May 14, 2021 | READYPREP CHG, 2% Chlorhexidine Gluconate Cloth, 2 9x10.5 in (22.9x26.7 cm) D... | Superpotent Drug: Product is above specification for active ingredient, 2% Chlorhexidine Gluconate. | Class III | Medline Industries Inc |
| May 3, 2021 | 1% Lidocaine HCl Injection, USP, 300 mg/30 mL (10 mg/mL), 30 mL Single-dose v... | Labeling: Label Mix-Up: some vials labeled to contain 0.5% Bupivacaine Hydrochloride Injection, U... | Class I | PFIZER, INC |
| May 3, 2021 | 0.5% Bupivacaine Hydrochloride Injection, USP, 150 mg/30 mL (5 mg/mL), 30 mL ... | Labeling: Label Mix-Up: some vials labeled to contain 0.5% Bupivacaine Hydrochloride Injection, U... | Class I | PFIZER, INC |
| May 3, 2021 | Thiamine HCl Injection, USP 200 mg/2 mL (100mg/mL), 2 mL vials, packaged in 2... | Labeling: Incorrect or Missing Lot and/or Exp Date: Cartons with the correct lot number 200906 co... | Class III | Mylan Institutional LLC |
| Mar 11, 2021 | Phenylephrine HCl Injection, USP, 10 mg per mL, 1 mL per Single-Dose Vial pac... | Lack of Assurance of Sterility: customer complaints of loose crimped vial overseals which may res... | Class II | Sagent Pharmaceuticals Inc |
| Mar 10, 2021 | aulief (Organic Camphor 3.00% Organic Menthol 5.00%), topical pain relief, pa... | CGMP deviations: Product being recalled as it was made in the same facility where contamination w... | Class II | China Gel Inc |
| Mar 10, 2021 | CHINA_GEL (Camphor 3.00%, Menthol 5.00%) A TOPICAL PAIN RELIEVER, packaged as... | CGMP deviations: Product being recalled as it was made in the same facility where contamination w... | Class II | China Gel Inc |
| Mar 10, 2021 | CHINA-GEL WHITE (Camphor 3.00%, Menthol 5.00%), A TOPICAL PAIN RELIEVER, pack... | CGMP deviations: Product being recalled as it was made in the same facility where contamination w... | Class II | China Gel Inc |
| Mar 9, 2021 | 0.9% SODIUM CHLORIDE Irrigation, USP 1000 mL Semi-Rigid Bottle, Rx only, Manu... | Presence of particulate matter.one confirmed customer report of particulate matter within two se... | Class II | ICU Medical Inc |
| Mar 8, 2021 | Gabapentin Oral Solution, 250 mg/5 mL, 5 mL per unit dose cup, four unit dose... | Failed Impurities/Degradation Specifications; out of specification for unknown impurity observed ... | Class II | Akorn, Inc. |
| Mar 2, 2021 | Acetaminophen, Extra Strength, Aspirin Free, 500 MG Tablets, 100-count bottle... | Labeling: Label Mix-up; The bottle of over-the-counter Acetaminophen 500mg Extra Strength, 100 co... | Class I | A-S Medication Solutions LLC. |
| Jan 27, 2021 | Cisatracurium Besylate Injection, USP, 10mg per 5mL (2 mg per mL), Single-Dos... | Labeling: Label mix-up: Carton of Cisatracurium Besylate Injection, USP was observed to contain t... | Class I | Meitheal Pharmaceuticals Inc |
| Jan 1, 2021 | Chlorhexidine Gluconate Oral Rinse USP 0.12%, packaged in a) 15 mL x 30 Unit ... | cGMP deviations: The firm was notified of the manufacturer's expanded recall. | Class II | Precision Dose Inc. |
| Dec 28, 2020 | Levetiracetam Oral Solution, 100 mg/mL, 16 fl oz (473 mL) bottle, Rx Only, HI... | Defective container: Customer complaints for oral solution leaking from bottles. | Class II | Akorn, Inc. |
| Dec 28, 2020 | Paroex (Chlorhexidine Gluconate) Oral Rinse, USP 0.12%, Alcohol Free, Rx only... | cGMP Deviations; FDA inspection of manufacturing facility observed potential Burkholderia cepacia... | Class II | Sunstar Americas, Inc. |
| Dec 23, 2020 | Ketorolac Tromethamine Injection, USP, 30 mg per mL, packaged in 1 mL Single ... | Presence of Particulate Matter - found in reserve sample vials at the firm. | Class I | Fresenius Kabi USA, LLC |
| Dec 17, 2020 | Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), package... | Presence of Particulate Matter - found in reserve sample vials at the firm. | Class II | Fresenius Kabi USA, LLC |
| Dec 10, 2020 | Sensorcaine-MPF (Bupivacaine HCl and Epinephrine Injection, USP), 0.5%, 150 m... | Subpotent Drug: Low out-of-specification assay results for the epinephrine component. | Class II | Fresenius Kabi USA, LLC |
| Dec 9, 2020 | Hydroxyzine Hydrochloride Oral Solution, USP (Syrup), 10 mg/5 mL, packaged in... | Failed Impurities/Degradation Specification: OOS for the following - unknown degradant/impurity, ... | Class II | Morton Grove Pharmaceuticals, Inc. |
| Nov 17, 2020 | Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg / 50 mL (4 mcg... | Cross Contamination with other products: trace amounts of lidocaine | Class I | Fresenius Kabi USA, LLC |
| Nov 17, 2020 | DOXOrubicin Hydrochloride Injection, USP, 10 mg / 5 mL (2 mg / mL), 5 mL fill... | Cross Contamination with Other Products: trace amounts of octreotide found during testing | Class III | Fresenius Kabi USA, LLC |
| Oct 27, 2020 | Paroex (chlorhexidine gluconate) Oral Rinse, USP 0.12%, Alcohol Free, Rx only... | Microbial Contamination of Non-sterile Products: contamination with Burkholderia lata. | Class I | Sunstar Americas, Inc. |
| Oct 7, 2020 | Bupivacaine Hydrochloride in 8.25% Dextrose Injection, USP Spinal 0.75% (15 m... | Presence of particulate matter in solution - black and transparent particles | Class II | Baxter Healthcare Corporation |
| Sep 3, 2020 | Eye Itch Relief, Ketotifen Fumarate Ophthalmic Solution 0.035%, Sterile, 5 mL... | CGMP Deviations | Class II | Akorn, Inc. |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.